Scientific Research Team

The Scientific Research Team at WaveBreak is responsible for investigating and characterizing the fleeting protein intermediates central to neurodegenerative disease pathways. They leverage WaveBreak's unique drug discovery platform to develop small-molecule therapeutics that target these transient oligomers, aiming to interrupt their molecular mechanisms. The team focuses on translating their findings into novel treatments for Parkinson's disease, Lewy body dementia, Alzheimer's disease, and ALS.